Cargando…

Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan

BACKGROUND: This study searches the National Health Insurance Research Database (NHIRD) used in a previous project, aiming for reconstructing possible cerebrovascular disease-related groups (DRG),and estimating the costs between cerebrovascular disease and related diseases. METHODS AND MATERIALS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Hsienhsueh Elley, Hong, Yu-Chiang, Chang, Ku-Chou, Shih, Chun-Chuan, Hung, Jen-Wen, Liu, Chia-Wei, Tan, Teng-Yeow, Huang, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903523/
https://www.ncbi.nlm.nih.gov/pubmed/24475108
http://dx.doi.org/10.1371/journal.pone.0086351
_version_ 1782301102916501504
author Chiu, Hsienhsueh Elley
Hong, Yu-Chiang
Chang, Ku-Chou
Shih, Chun-Chuan
Hung, Jen-Wen
Liu, Chia-Wei
Tan, Teng-Yeow
Huang, Chih-Cheng
author_facet Chiu, Hsienhsueh Elley
Hong, Yu-Chiang
Chang, Ku-Chou
Shih, Chun-Chuan
Hung, Jen-Wen
Liu, Chia-Wei
Tan, Teng-Yeow
Huang, Chih-Cheng
author_sort Chiu, Hsienhsueh Elley
collection PubMed
description BACKGROUND: This study searches the National Health Insurance Research Database (NHIRD) used in a previous project, aiming for reconstructing possible cerebrovascular disease-related groups (DRG),and estimating the costs between cerebrovascular disease and related diseases. METHODS AND MATERIALS: We conducted a nationwide retrospective cohort study in stroke inpatients, we examined the overall costs in 3 municipalities in Taiwan, by evaluating the possible costs of the expecting diagnosis related group (DRG) by using the international classification of diseases version-9 (ICD-9) system, and the overall analysis of the re-admission population that received traditional Chinese medicine (TCM) treatment and those who did not. RESULTS: The trend demonstrated that the non-participant costs were consistent with the ICD-9 categories (430 to 437) because similarities existed between years 2006 to 2007. Among the TCM patients, a wide variation and additional costs were found compared to non-TCM patients during these 2 years. The average re-admission duration was significantly shorter for TCM patients, especially those initially diagnosed with ICD 434 during the first admission. In addition, TCM patients demonstrated more severe general symptoms, which incurred high conventional treatment costs, and could result in re-admission for numerous reasons. However, in Disease 7 of ICD-9 category, representing the circulatory system was most prevalent in non-TCM inpatients, which was the leading cause of re-admission. CONCLUSION: We concluded that favorable circulatory system outcomes were in adjuvant TCM treatment inpatients, there were less re-admission for circulatory system events and a two-third reduction of re-admission within ICD-9 code 430 to 437, compared to non-TCM ones. However, there were shorter re-admission duration other than circulatory system events by means of unfavorable baseline condition.
format Online
Article
Text
id pubmed-3903523
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39035232014-01-28 Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan Chiu, Hsienhsueh Elley Hong, Yu-Chiang Chang, Ku-Chou Shih, Chun-Chuan Hung, Jen-Wen Liu, Chia-Wei Tan, Teng-Yeow Huang, Chih-Cheng PLoS One Research Article BACKGROUND: This study searches the National Health Insurance Research Database (NHIRD) used in a previous project, aiming for reconstructing possible cerebrovascular disease-related groups (DRG),and estimating the costs between cerebrovascular disease and related diseases. METHODS AND MATERIALS: We conducted a nationwide retrospective cohort study in stroke inpatients, we examined the overall costs in 3 municipalities in Taiwan, by evaluating the possible costs of the expecting diagnosis related group (DRG) by using the international classification of diseases version-9 (ICD-9) system, and the overall analysis of the re-admission population that received traditional Chinese medicine (TCM) treatment and those who did not. RESULTS: The trend demonstrated that the non-participant costs were consistent with the ICD-9 categories (430 to 437) because similarities existed between years 2006 to 2007. Among the TCM patients, a wide variation and additional costs were found compared to non-TCM patients during these 2 years. The average re-admission duration was significantly shorter for TCM patients, especially those initially diagnosed with ICD 434 during the first admission. In addition, TCM patients demonstrated more severe general symptoms, which incurred high conventional treatment costs, and could result in re-admission for numerous reasons. However, in Disease 7 of ICD-9 category, representing the circulatory system was most prevalent in non-TCM inpatients, which was the leading cause of re-admission. CONCLUSION: We concluded that favorable circulatory system outcomes were in adjuvant TCM treatment inpatients, there were less re-admission for circulatory system events and a two-third reduction of re-admission within ICD-9 code 430 to 437, compared to non-TCM ones. However, there were shorter re-admission duration other than circulatory system events by means of unfavorable baseline condition. Public Library of Science 2014-01-27 /pmc/articles/PMC3903523/ /pubmed/24475108 http://dx.doi.org/10.1371/journal.pone.0086351 Text en © 2014 Chiu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chiu, Hsienhsueh Elley
Hong, Yu-Chiang
Chang, Ku-Chou
Shih, Chun-Chuan
Hung, Jen-Wen
Liu, Chia-Wei
Tan, Teng-Yeow
Huang, Chih-Cheng
Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title_full Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title_fullStr Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title_full_unstemmed Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title_short Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan
title_sort favorable circulatory system outcomes as adjuvant traditional chinese medicine (tcm) treatment for cerebrovascular diseases in taiwan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903523/
https://www.ncbi.nlm.nih.gov/pubmed/24475108
http://dx.doi.org/10.1371/journal.pone.0086351
work_keys_str_mv AT chiuhsienhsuehelley favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT hongyuchiang favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT changkuchou favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT shihchunchuan favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT hungjenwen favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT liuchiawei favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT tantengyeow favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan
AT huangchihcheng favorablecirculatorysystemoutcomesasadjuvanttraditionalchinesemedicinetcmtreatmentforcerebrovasculardiseasesintaiwan